The purpose of the present study was to explore the association between Thr92Ala and metabolic phenotypes such as BMI, fasting glycemic traits, plasma lipid levels, and hypertension risk to provide more evidence to support the association between the polymorphism or activity of Dio2 and metabolic disorders beyond the HPT axis. Here, DIO2 is linked to hypertensive disorder.